RxDoctor Payments Data

Vandana Nanda, MD

MOHS-Micrographic Surgery · Charlottesville, VANPI 1770546517

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 22 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 12 manufacturers reported payments, led by AbbVie at 25.7% of the total. Reporting peaked in 2024 at $290 and has fallen 56.1% since, to $127 in 2025. That places this record below the midpoint for mohs-micrographic surgery clinicians in VA, where the typical reported total is $1,276.

$821in general payments, 2019–2025

Across 22 payments — averaging $37.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$211
  • Organogenesis Inc.$130
  • Sanofi$118
  • Kerecis Limited$116
  • Lilly USA, LLC$91
  • Genentech USA, Inc.$29
  • plus $127 from 6 others

What the payments were for

  • Food & beverage$821100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$821 in reported general payments places this provider in the 40th percentile of 36 mohs-micrographic surgery providers in Virginia.

See all mohs-micrographic surgery providers in Virginia

Medicare billing

Part B allowed, 2024
$1,302,424
Medicare patients
1,082
Services billed
3,922

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Fluorouracil84$6,338
Mupirocin23$172
Cephalexin19$69
Ciprofloxacin Hcl11$36

Paid to pharmacies, not to this prescriber.

Other mohs-micrographic surgery in Charlottesville

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →